Integrative Logic Recognized for Work on Behalf of Galderma Laboratories’ Differin and Cetaphil Brands

Press Release  |  www.prweb.com | 9 hours 15 minutes ago

PR: Differin® website earns eHealthcare Leadership Award; Cetaphil® Skin Care Club® is a finalist for MM&M Awards 2009 Atlanta (PRWEB) November 20, 2009 -- Integrative Logic, a leading full-service, integrated database marketing provider based in Atla

http://www.prweb.com/releases/2009/11/prweb3239254.htm

Galderma wins Japanese approval for Differin gel 0.1%

News  |  www.pharmaceutical-business-review.com | Jul 17, 2008

Galderma Pharma has announced that Japans Ministry of Health, Labor and Welfare has approved Differin gel 0.1%, a novel topical treatment for acne vulgaris in Japan.

http://www.pharmaceutical-business-review.com/article_news.asp?guid=E1A298A5-27AD-48A4-8518-C2C7DECA9101

Galderma Pharma S.A. Announces Approval for Differin(R) Gel 0.1% in Japan Based on the Largest Ever Clinical Program for Acne in Japan

News  |  www.biospace.com | Jul 17, 2008

LAUSANNE, Switzerland, July 16 /PRNewswire/ -- Galderma Pharma S.A., a global specialty pharmaceutical company focused on dermatology, announced today that Japan's Ministry of Health, Labor and Welfare has approved Differin(R) Gel 0.1% (adapalene), a novel topical treatment for acne vulgaris in

http://www.biospace.com/news_story.aspx?StoryID=103579&full=1

New Talking Acne With Your Teen Campaign Offers Advice to Moms on How to Help Kids Start the School Year With Clearer Skin

Press Release  |  www.prnewswire.com | Jul 15, 2008

D., together with leading dermatologist Linda Stein Gold, M.D., today helped Galderma, the maker of Differin(R) acne products launch the Talking Acne with Your Teen campaign. Geared to moms of children ages 11 to 18, the campaign features an E-guide and Web site (http://www.MyChildsAcne.

http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=109&STORY=/www/story/07-15-2008/0004849169&EDATE=

GALDERMA

Fort Worth, Texas, June 20, 2007 /PRNewswire/ - Galderma Laboratories, L.P., announced today that the U.S. Food and Drug Administration (FDA) has approved Differin(R) (adapalene) Gel, 0.3%, a new, higher concentration formulation of Differin(R) (adapalene) 0.

http://www.galderma.com/News.asp?rub=40&Id=87&limitYear=0&limitNews=0&currYear=2007

HON - News : Health Highlights: Dec.6, 2007

Tests on a number of the best-selling dietary supplements in the United States found that about one-quarter of them contained traces of steroids and 11.5 percent contained banned stimulants, the Associated Press reported.

http://www.hon.ch/News/HSN/610681.html

Allergan buys QLT's acne drug

News  |  www.pharmaceutical-business-review.com | Jun 10, 2008

QLT has announced that QLT USA, its wholly-owned subsidiary, has entered into an asset purchase agreement with Allergan Sales, a wholly-owned subsidiary of Allergan to fully divest QLT's worldwide rights to Aczone, a prescription topical medicine approved in the US and Canada for the treatment of

http://www.pharmaceutical-business-review.com/article_news.asp?guid=D1D140C7-0DE3-4403-9E7C-DA61F0FDB4FF

Skinvisible Announces Licensing Agreement for Adapalene

Press Release  |  www.prnewswire.com | Jan 30, 2008

The Company's first acne product enters the $2.8 billion worldwide market LAS VEGAS, Jan. 30 /PRNewswire-FirstCall/ -- Skinvisible, Inc. (OTC Bulletin Board: SKVI; http://www.skinvisible.

http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=109&STORY=/www/story/01-30-2008/0004746376&EDATE=

GALDERMA

Osaka, March 7, 2006 Shionogi & Co., Ltd. (Head Office: Osaka, President: Motozo Shiono) and Galderma KK (Head Office: Tokyo, President: Humberto C.

http://www.galderma.com/News.asp?rub=40&Id=81&limitYear=1&limitNews=0&currYear=2006

GALDERMA

> New Galderma Quality Report Reveals New Trends For Dermatology Fort Worth, TX July 17, 2007 Galderma Laboratories, L.P. has published the second edition of the Galderma Quality Report for Dermatology & Managed Care.

http://www.galderma.com/News.asp?rub=40&Id=0&limitYear=0&limitNews=0&currYear=2007